Career history of Todd W. Rich
Former positions of Todd W. Rich
| Companies | Position | Start | End |
|---|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 2008-08-25 | 2014-03-18 |
| Independent Dir/Board Member | 2008-08-25 | 2014-03-18 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2011-03-31 | 2012-08-31 |
Training of Todd W. Rich
| Amherst College | Undergraduate Degree |
| University of Michigan | Graduate Degree |
| Wayne State University (Michigan) | Doctorate Degree |
| Stanford University | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
- Stock Market
- Insiders
- Todd W. Rich
- Experience
